161 related articles for article (PubMed ID: 38338836)
1. Networked Cluster Formation via Trigonal Lipid Modules for Augmented Ex Vivo NK Cell Priming.
Park J; Kim S; Jangid AK; Park HW; Kim K
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338836
[TBL] [Abstract][Full Text] [Related]
2. Tailoring tumor-recognizable hyaluronic acid-lipid conjugates to enhance anticancer efficacies of surface-engineered natural killer cells.
Lee CE; Kim S; Park HW; Lee W; Jangid AK; Choi Y; Jeong WJ; Kim K
Nano Converg; 2023 Dec; 10(1):56. PubMed ID: 38097911
[TBL] [Abstract][Full Text] [Related]
3. Biomaterial-Mediated Exogenous Facile Coating of Natural Killer Cells for Enhancing Anticancer Efficacy toward Hepatocellular Carcinoma.
Jangid AK; Kim S; Kim HJ; Kim K
Bioconjug Chem; 2023 Oct; 34(10):1789-1801. PubMed ID: 37726892
[TBL] [Abstract][Full Text] [Related]
4. Optimized Design of Hyaluronic Acid-Lipid Conjugate Biomaterial for Augmenting CD44 Recognition of Surface-Engineered NK Cells.
Park HW; Lee W; Kim S; Jangid AK; Park J; Lee CE; Kim K
Biomacromolecules; 2024 Mar; 25(3):1959-1971. PubMed ID: 38379131
[TBL] [Abstract][Full Text] [Related]
5. Ex Vivo Surface Decoration of Phenylboronic Acid onto Natural Killer Cells for Sialic Acid-Mediated Versatile Cancer Cell Targeting.
Jangid AK; Kim S; Park HW; Kim HJ; Kim K
Biomacromolecules; 2024 Jan; 25(1):222-237. PubMed ID: 38130077
[TBL] [Abstract][Full Text] [Related]
6. Human NK cells licensed by killer Ig receptor genes have an altered cytokine program that modifies CD4+ T cell function.
Lin L; Ma C; Wei B; Aziz N; Rajalingam R; Yusung S; Erlich HA; Trachtenberg EA; Targan SR; McGovern DP; Heath JR; Braun J
J Immunol; 2014 Jul; 193(2):940-9. PubMed ID: 24935928
[TBL] [Abstract][Full Text] [Related]
7. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: Priming of NK cells by IL-18.
Chaix J; Tessmer MS; Hoebe K; Fuséri N; Ryffel B; Dalod M; Alexopoulou L; Beutler B; Brossay L; Vivier E; Walzer T
J Immunol; 2008 Aug; 181(3):1627-31. PubMed ID: 18641298
[TBL] [Abstract][Full Text] [Related]
9. Innate Cytokine Induced Early Release of IFNγ and CC Chemokines from Hypoxic Human NK Cells Is Independent of Glucose.
Velásquez SY; Himmelhan BS; Kassner N; Coulibaly A; Schulte J; Brohm K; Lindner HA
Cells; 2020 Mar; 9(3):. PubMed ID: 32192004
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stromal Cells Prevent Allostimulation In Vivo and Control Checkpoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation.
Consentius C; Akyüz L; Schmidt-Lucke JA; Tschöpe C; Pinzur L; Ofir R; Reinke P; Volk HD; Juelke K
Stem Cells; 2015 Oct; 33(10):3087-99. PubMed ID: 26184374
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell and NK cell reciprocal cross talk promotes gamma interferon-dependent immunity to blood-stage Plasmodium chabaudi AS infection in mice.
Ing R; Stevenson MM
Infect Immun; 2009 Feb; 77(2):770-82. PubMed ID: 19015248
[TBL] [Abstract][Full Text] [Related]
12. Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptors.
Sabry M; Tsirogianni M; Bakhsh IA; North J; Sivakumaran J; Giannopoulos K; Anderson R; Mackinnon S; Lowdell MW
J Immunol; 2011 Dec; 187(12):6227-34. PubMed ID: 22084431
[TBL] [Abstract][Full Text] [Related]
13. Shaping of Natural Killer Cell Antitumor Activity by
Granzin M; Wagner J; Köhl U; Cerwenka A; Huppert V; Ullrich E
Front Immunol; 2017; 8():458. PubMed ID: 28491060
[TBL] [Abstract][Full Text] [Related]
14. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models.
Shime H; Kojima A; Maruyama A; Saito Y; Oshiumi H; Matsumoto M; Seya T
J Innate Immun; 2014; 6(3):293-305. PubMed ID: 24192491
[TBL] [Abstract][Full Text] [Related]
16. Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection.
Werner JM; Serti E; Chepa-Lotrea X; Stoltzfus J; Ahlenstiel G; Noureddin M; Feld JJ; Liang TJ; Rotman Y; Rehermann B
Hepatology; 2014 Oct; 60(4):1160-9. PubMed ID: 24700342
[TBL] [Abstract][Full Text] [Related]
17. TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells.
Stephenson RM; Lim CM; Matthews M; Dietsch G; Hershberg R; Ferris RL
Cancer Immunol Immunother; 2013 Aug; 62(8):1347-57. PubMed ID: 23685782
[TBL] [Abstract][Full Text] [Related]
18. Activation mechanisms of natural killer cells during influenza virus infection.
Hwang I; Scott JM; Kakarla T; Duriancik DM; Choi S; Cho C; Lee T; Park H; French AR; Beli E; Gardner E; Kim S
PLoS One; 2012; 7(12):e51858. PubMed ID: 23300570
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-gamma responses to malaria.
Newman KC; Korbel DS; Hafalla JC; Riley EM
PLoS Pathog; 2006 Dec; 2(12):e118. PubMed ID: 17154717
[TBL] [Abstract][Full Text] [Related]
20. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
